Lord, Abbett & Co’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-86,487
| Closed | -$4.34M | – | 569 |
|
|
2024
Q1 | $4.34M | Sell |
86,487
-72,832
| -46% | -$3.66M | 0.01% | 489 |
|
|
2023
Q4 | $9.62M | Sell |
159,319
-16,718
| -9% | -$1.01M | 0.03% | 394 |
|
|
2023
Q3 | $10M | Sell |
176,037
-18,666
| -10% | -$1.06M | 0.04% | 386 |
|
|
2023
Q2 | $9.93M | Buy |
+194,703
| New | +$9.93M | 0.03% | 418 |
|